Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amol A Sura

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Opinion in Ophthalmology|September 27, 2022
Peripheral ulcerative keratitis due to systemic diseasesAmol A Sura, Rex M McCallum
JAMA Ophthalmology|November 20, 2025
Treatment of Ligneous Conjunctivitis With Intravenous PlasminogenHazem M Mousa, Amy M Fowler, Amol A Sura
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 5, 2019
Vision Loss As a Presenting Feature of Wernicke EncephalopathyAmol A Sura, Joel K Cure, Lanning B Kline
Orbit (Amsterdam, Netherlands)|August 6, 2025
Bilateral upper lid symblepharon following posterior approach ptosis surgeryJames O Robbins, Irene T Lee, Julie A Woodward, et al.
Investigative Ophthalmology & Visual Science|November 13, 2020
Measuring the Contributions of Basal Laminar Deposit and Bruch's Membrane in Age-Related Macular DegenerationAmol A Sura, Ling Chen, Jeffrey D Messinger, et al.
American Journal of Ophthalmology Case Reports|April 25, 2022
Occult cause of uveitis-glaucoma-hyphema syndrome diagnosed during treatment with endocyclophotocoagulation (ECP)Amol A Sura, Amit K Reddy, Kelly Babic, et al.
Ocular Immunology and Inflammation|January 26, 2023
Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) TrialAmol A Sura, Yuwei Sun, Amit K Reddy, et al.
Journal of Ophthalmic Inflammation and Infection|June 9, 2023
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trialAmit K Reddy, D Claire Miller, Amol A Sura, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Ophthalmology|September 27, 2022
Peripheral ulcerative keratitis due to systemic diseasesAmol A Sura, Rex M McCallum
JAMA Ophthalmology|November 20, 2025
Treatment of Ligneous Conjunctivitis With Intravenous PlasminogenHazem M Mousa, Amy M Fowler, Amol A Sura
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 5, 2019
Vision Loss As a Presenting Feature of Wernicke EncephalopathyAmol A Sura, Joel K Cure, Lanning B Kline
Orbit (Amsterdam, Netherlands)|August 6, 2025
Bilateral upper lid symblepharon following posterior approach ptosis surgeryJames O Robbins, Irene T Lee, Julie A Woodward, et al.
Investigative Ophthalmology & Visual Science|November 13, 2020
Measuring the Contributions of Basal Laminar Deposit and Bruch's Membrane in Age-Related Macular DegenerationAmol A Sura, Ling Chen, Jeffrey D Messinger, et al.
American Journal of Ophthalmology Case Reports|April 25, 2022
Occult cause of uveitis-glaucoma-hyphema syndrome diagnosed during treatment with endocyclophotocoagulation (ECP)Amol A Sura, Amit K Reddy, Kelly Babic, et al.
Ocular Immunology and Inflammation|January 26, 2023
Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) TrialAmol A Sura, Yuwei Sun, Amit K Reddy, et al.
Journal of Ophthalmic Inflammation and Infection|June 9, 2023
Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trialAmit K Reddy, D Claire Miller, Amol A Sura, et al.
Pageof 1